A new generation of implantable electrodes
Therapeutic outcomes from clinical neural implants are limited by their mechanical properties. Their stiff and rigid designs present a mechanical mismatch compared to the soft and curved tissues they interface with, thereby constraining the physiological motion dynamics of the nervous system.
At Neurosoft Bioelectronics, we are addressing this issue by engineering elasticity in thin film materials to manufacture implantable electrodes that are much softer and flexible, and that can seamlessly interface with the nervous system.
Latest News
A groundbreaking technology from the LSBI makes it to the market !
It is often a long and laborious process to bring a new technology from the laboratory to the market. According to Stephanie Lacour, head of the Laboratory for Soft Bioelectronic Interfaces (LSBI) at EPFL, “These discoveries can be so far ahead of the curve that...
Florian Fallegger winner of the BridgeFunding Program
Congratulations to Florian Fallegger for being one of the 7 winners of the Bridge Funding Proof of Concept projects! We are looking forward to having you full-time on board! Link to the original LinkedIn publication.
Swiss Healthcare Startups Finalists
We are very happy and proud to have been selected as part of the Top 10 Finalists of the SHS #SmarterHealthcare Boost Program 2020! #finalists #NeurosoftBio Link to the original LinkedIn publication.
Supported by
